Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 9707252, 13 pages
http://dx.doi.org/10.1155/2016/9707252
Review Article

Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive Tract

1Division of Immunology, Department of Pathology, University of Cape Town, Faculty of Health Sciences, Observatory 7925, South Africa
2International Centre for Genetic Engineering and Biotechnology and Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa
3MRC/UCT Receptor Biology Research Unit, Department of Integrative Biomedical Sciences and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa
4SAMRC Gynaecology Cancer Research Centre, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa

Received 26 January 2016; Revised 26 May 2016; Accepted 29 May 2016

Academic Editor: Jacek Tabarkiewicz

Copyright © 2016 Anthonio O. Adefuye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. N. Jabbour, K. J. Sales, R. D. Catalano, and J. E. Norman, “Inflammatory pathways in female reproductive health and disease,” Reproduction, vol. 138, no. 6, pp. 903–919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. N. Serhan, N. Chiang, and T. E. Van Dyke, “Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators,” Nature Reviews Immunology, vol. 8, no. 5, pp. 349–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Adefuye, A. A. Katz, and K. J. Sales, “The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid,” Pathology Research International, vol. 2014, Article ID 748740, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. O'Leary, M. J. Jasper, G. M. Warnes, D. T. Armstrong, and S. A. Robertson, “Seminal plasma regulates endometrial cytokine expression, leukocyte recruitment and embryo development in the pig,” Reproduction, vol. 128, no. 2, pp. 237–247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Sharkey, K. P. Tremellen, M. J. Jasper, K. Gemzell-Danielsson, and S. A. Robertson, “Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus,” Journal of Immunology, vol. 188, no. 5, pp. 2445–2454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Maegawa, M. Kamada, M. Irahara et al., “A repertoire of cytokines in human seminal plasma,” Journal of Reproductive Immunology, vol. 54, no. 1-2, pp. 33–42, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. D. J. Sharkey, A. M. Macpherson, K. P. Tremellen, and S. A. Robertson, “Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells,” Molecular Human Reproduction, vol. 13, no. 7, pp. 491–501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. E. Schjenken and S. A. Robertson, “Seminal fluid and immune adaptation for pregnancy—comparative biology in mammalian species,” Reproduction in Domestic Animals, vol. 49, pp. 27–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Newton and V. M. Dixit, “Signaling in innate immunity and inflammation,” Cold Spring Harbor Perspectives in Biology, vol. 4, no. 3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. W. Horne, S. J. Stock, and A. E. King, “Innate immunity and disorders of the female reproductive tract,” Reproduction, vol. 135, no. 6, pp. 739–749, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Johansson and N. Y. Lycke, “Immunology of the human genital tract,” Current Opinion in Infectious Diseases, vol. 16, no. 1, pp. 43–49, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. King, H. O. D. Critchley, and R. W. Kelly, “Innate immune defences in the human endometrium,” Reproductive Biology and Endocrinology, vol. 1, article 116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Nasu and H. Narahara, “Pattern recognition via the toll-like receptor system in the human female genital tract,” Mediators of Inflammation, vol. 2010, Article ID 976024, 12 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Bernstein, “Immunologic disorders of the female and male reproductive tract,” Annals of Allergy, Asthma and Immunology, vol. 108, no. 6, pp. 390–395, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. K. Lee, C. J. Kim, D.-J. Kim, and J.-H. Kang, “Immune cells in the female reproductive tract,” Immune Network, vol. 15, no. 1, pp. 16–26, 2015. View at Publisher · View at Google Scholar
  16. N. Iijima, J. M. Thompson, and A. Iwasaki, “Dendritic cells and macrophages in the genitourinary tract,” Mucosal Immunology, vol. 1, no. 6, pp. 451–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Philip, D. A. Rowley, and H. Schreiber, “Inflammation as a tumor promoter in cancer induction,” Seminars in Cancer Biology, vol. 14, no. 6, pp. 433–439, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Sirois, K. Sayasith, K. A. Brown, A. E. Stock, N. Bouchard, and M. Doré, “Cyclooxygenase-2 and its role in ovulation: a 2004 account,” Human Reproduction Update, vol. 10, no. 5, pp. 373–385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. S. Richards, D. L. Russell, S. Ochsner, and L. L. Espey, “Ovulation: new dimensions and new regulators of the inflammatory-like response,” Annual Review of Physiology, vol. 64, pp. 69–92, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. L. L. Espey, “Ovulation as an inflammatory reaction: a hypothesis,” Biology of Reproduction, vol. 22, no. 1, pp. 73–106, 1980. View at Publisher · View at Google Scholar · View at Scopus
  21. L. L. Espey, “Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction,” Biology of Reproduction, vol. 50, no. 2, pp. 233–238, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. J. S. Richards, Z. Liu, and M. Shimada, “Immune-like mechanisms in ovulation,” Trends in Endocrinology and Metabolism, vol. 19, no. 6, pp. 191–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Evans and L. A. Salamonsen, “Inflammation, leukocytes and menstruation,” Reviews in Endocrine and Metabolic Disorders, vol. 13, no. 4, pp. 277–288, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-J. Zhang, Z.-M. Xu, C.-M. Zhang et al., “Pyrrolidine dithiocarbamate inhibits nuclear factor-κB pathway activation, and regulates adhesion, migration, invasion and apoptosis of endometriotic stromal cells,” Molecular Human Reproduction, vol. 17, no. 3, pp. 175–181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. D. B. Hardy, B. A. Janowski, D. R. Corey, and C. R. Mendelson, “Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-κB activation of cyclooxygenase 2 expression,” Molecular Endocrinology, vol. 20, no. 11, pp. 2724–2733, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Dekel, Y. Gnainsky, I. Granot, and G. Mor, “Inflammation and implantation,” American Journal of Reproductive Immunology, vol. 63, no. 1, pp. 17–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Mor, I. Cardenas, V. Abrahams, and S. Guller, “Inflammation and pregnancy: the role of the immune system at the implantation site,” Annals of the New York Academy of Sciences, vol. 1221, no. 1, pp. 80–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Jasper, A. S. Care, B. Sullivan, W. V. Ingman, J. D. Aplin, and S. A. Robertson, “Macrophage-derived LIF and IL1B regulate alpha(1,2)fucosyltransferase 2 (Fut2) expression in mouse uterine epithelial cells during early pregnancy,” Biology of Reproduction, vol. 84, no. 1, pp. 179–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Yoshinaga, “Review of factors essential for blastocyst implantation for their modulating effects on the maternal immune system,” Seminars in Cell and Developmental Biology, vol. 19, no. 2, pp. 161–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. G. Kennedy, C. Gillio-Meina, and S. H. Phang, “Prostaglandins and the initiation of blastocyst implantation and decidualization,” Reproduction, vol. 134, no. 5, pp. 635–643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Romero, J. Espinoza, L. F. Gonçalves, J. P. Kusanovic, L. A. Friel, and J. K. Nien, “Inflammation in preterm and term labour and delivery,” Seminars in Fetal and Neonatal Medicine, vol. 11, no. 5, pp. 317–326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Osman, A. Young, M. A. Ledingham et al., “Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term,” Molecular Human Reproduction, vol. 9, no. 1, pp. 41–45, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. D. M. Slater, W. J. B. Dennes, J. S. Campa, L. Poston, and P. R. Bennett, “Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy,” Molecular Human Reproduction, vol. 5, no. 9, pp. 880–884, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Zuo, Z. M. Lei, C. V. Rao, M. Pietrantoni, and V. D. Cook, “Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries,” Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 3, pp. 894–899, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. A. E. King, R. W. Kelly, J.-M. Sallenave, A. D. Bocking, and J. R. G. Challis, “Innate immune defences in the human uterus during pregnancy,” Placenta, vol. 28, no. 11-12, pp. 1099–1106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. B. Sennström, G. Ekman, G. Westergren-Thorsson et al., “Human cervical ripening, an inflammatory process mediated by cytokines,” Molecular Human Reproduction, vol. 6, no. 4, pp. 375–381, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Xu, N. Alfaidy, and J. R. G. Challis, “Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 3, pp. 1353–1361, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. S. C. Riley, R. Leask, F. C. Denison, K. Wisely, A. A. Calder, and D. C. Howe, “Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition,” Journal of Endocrinology, vol. 162, no. 3, pp. 351–359, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. D. E. Soper, “Pelvic inflammatory disease,” Obstetrics & Gynecology, vol. 116, no. 2, pp. 419–428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Dessus-Babus, T. L. Darville, F. P. Cuozzo, K. Ferguson, and P. B. Wyrick, “Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis,” Infection and Immunity, vol. 70, no. 6, pp. 3234–3248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. R. M. Johnson, “Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion,” Infection and Immunity, vol. 72, no. 7, pp. 3951–3960, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Sonnex, “Toll-like receptors and genital tract infection,” International Journal of STD and AIDS, vol. 21, no. 3, pp. 153–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Kanzler, F. J. Barrat, E. M. Hessel, and R. L. Coffman, “Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists,” Nature Medicine, vol. 13, no. 5, pp. 552–559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. C. R. Wira, J. V. Fahey, C. L. Sentman, P. A. Pioli, and L. Shen, “Innate and adaptive immunity in female genital tract: cellular responses and interactions,” Immunological Reviews, vol. 206, pp. 306–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. C. M. O'Connell, R. R. Ingalls, C. W. Andrews Jr., A. M. Scurlock, and T. Darville, “Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease,” The Journal of Immunology, vol. 179, no. 6, pp. 4027–4034, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. B. D. Taylor, T. Darville, R. E. Ferrell, C. M. Kammerer, R. B. Ness, and C. L. Haggerty, “Variants in toll-like receptor 1 and 4 genes are associated with chlamydia trachomatis among women with pelvic inflammatory disease,” Journal of Infectious Diseases, vol. 205, no. 4, pp. 603–609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. A. N. Viswanathan, D. Feskanich, E. S. Schernhammer, and S. E. Hankinson, “Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer,” Cancer Research, vol. 68, no. 7, pp. 2507–2513, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. R. E. Harris, R. T. Chlebowski, R. D. Jackson et al., “Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative,” Cancer Research, vol. 63, no. 18, pp. 6096–6101, 2003. View at Google Scholar · View at Scopus
  49. F. Modugno, R. B. Ness, C. Chen, and N. S. Weiss, “Inflammation and endometrial cancer: a hypothesis,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 12, pp. 2840–2847, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. S. P. Hussain, L. J. Hofseth, and C. C. Harris, “Radical causes of cancer,” Nature Reviews Cancer, vol. 3, no. 4, pp. 276–285, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Forman, D. Stockton, H. Møller et al., “Cancer prevalence in the UK: results from the EUROPREVAL study,” Annals of Oncology, vol. 14, no. 4, pp. 648–654, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Macciò and C. Madeddu, “Inflammation and ovarian cancer,” Cytokine, vol. 58, no. 2, pp. 133–147, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. M. F. Fathalla, “Incessant ovulation—a factor in ovarian neoplasia?” The Lancet, vol. 298, no. 7716, p. 163, 1971. View at Publisher · View at Google Scholar · View at Scopus
  54. M. F. Fathalla, “Incessant ovulation and ovarian cancer—a hypothesis re-visited,” Facts, Views & Visions in ObGyn, vol. 5, pp. 292–297, 2013. View at Google Scholar
  55. A. Maccio, G. Mantovani, E. Turnu, P. Artini, G. Contu, and A. Volpe, “Preovulatory human follicular fluid in vitro inhibits interleukin (IL)- 1α, IL-2, and production and expression of p55 chain IL-2 receptor of lymphomonocytes,” Fertility and Sterility, vol. 62, no. 2, pp. 327–332, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Nowak, E. Glowacka, M. Szpakowski et al., “Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors,” Neuroendocrinology Letters, vol. 31, no. 3, pp. 375–383, 2010. View at Google Scholar · View at Scopus
  57. T. V. Clendenen, E. Lundin, A. Zeleniuch-Jacquotte et al., “Circulating inflammation markers and risk of epithelial ovarian cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 5, pp. 799–810, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Ferrandina, F. O. Ranelletti, L. Lauriola et al., “Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer,” Gynecologic Oncology, vol. 85, no. 2, pp. 305–310, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. M. A. Altinoz and R. Korkmaz, “NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer,” Neoplasma, vol. 51, no. 4, pp. 239–247, 2004. View at Google Scholar · View at Scopus
  60. K. J. Sales and H. N. Jabbour, “Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium,” Reproduction, vol. 126, no. 5, pp. 559–567, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. T. E. Vaskivuo, F. Stenbäck, and J. S. Tapanainen, “Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-α, and NF-κB in human endometrial hyperplasia and carcinoma,” Cancer, vol. 95, no. 7, pp. 1463–1471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. M.-E. St-Germain, V. Gagnon, S. Parent, and E. Asselin, “Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-κB/IκB pathway,” Molecular Cancer, vol. 3, article 7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Ferrandina, F. Legge, F. O. Ranelletti et al., “Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome,” Cancer, vol. 95, no. 4, pp. 801–807, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Tsujii, S. Kawano, S. Tsuji, H. Sawaoka, M. Hori, and R. N. DuBois, “Cyclooxygenase regulates angiogenesis induced by colon cancer cells,” Cell, vol. 93, no. 5, pp. 705–716, 1998. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Tsujii and R. N. DuBois, “Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2,” Cell, vol. 83, no. 3, pp. 493–501, 1995. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Tsujii, S. Kawano, and R. N. DuBois, “Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, pp. 3336–3340, 1997. View at Google Scholar
  67. V. Beral, C. Hermon, N. Munoz, and S. S. Devesa, “Cervical cancer,” Cancer Surveys, vol. 19-20, pp. 265–285, 1994. View at Google Scholar · View at Scopus
  68. J. S. Smith, R. Herrero, C. Bosetti et al., “Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer,” Journal of the National Cancer Institute, vol. 94, no. 21, pp. 1604–1613, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. B. Goswami, M. Rajappa, M. Sharma, and A. Sharma, “Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies,” International Journal of Gynecological Cancer, vol. 18, no. 4, pp. 591–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. P. E. Castle, S. L. Hillier, L. K. Rabe et al., “An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV),” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 10, pp. 1021–1027, 2001. View at Google Scholar · View at Scopus
  71. Y. C. Yang, C. L. Chang, Y. W. Huang, and D. Y. Wang, “Possible cofactor in cervical carcinogenesis: proliferation index of the transformation zone in cervicitis,” Chang Gung Medical Journal, vol. 24, no. 10, pp. 615–620, 2001. View at Google Scholar · View at Scopus
  72. J. R. Schwebke and M. E. Zajackowski, “Effect of concurrent lower genital tract infections on cervical cancer screening,” Sexually Transmitted Infections, vol. 73, no. 5, pp. 383–386, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Sharma, M. Rajappa, A. Saxena, and M. Sharma, “Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix,” International Journal of Gynecological Cancer, vol. 17, no. 4, pp. 879–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. K. J. Sales and H. N. Jabbour, “Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology,” Prostaglandins and Other Lipid Mediators, vol. 71, no. 3-4, pp. 97–117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. D. H. Owen and D. F. Katz, “A review of the physical and chemical properties of human semen and the formulation of a semen simulant,” Journal of Andrology, vol. 26, no. 4, pp. 459–469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. S. A. Robertson, L. R. Guerin, J. J. Bromfield, K. M. Branson, A. C. Ahlström, and A. S. Care, “Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice,” Biology of Reproduction, vol. 80, no. 5, pp. 1036–1045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. L. M. Moldenhauer, K. R. Diener, D. M. Thring, M. P. Brown, J. D. Hayball, and S. A. Robertson, “Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy,” The Journal of Immunology, vol. 182, no. 12, pp. 8080–8093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. R. B. Ness and D. A. Grainger, “Male reproductive proteins and reproductive outcomes,” American Journal of Obstetrics & Gynecology, vol. 198, no. 6, pp. 620.e1–620.e4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Hamberg and B. Samuelsson, “Prostaglandins in human seminal plasma. Prostaglandins and related factors 46,” The Journal of Biological Chemistry, vol. 241, no. 2, pp. 257–263, 1966. View at Google Scholar · View at Scopus
  80. A. A. Templeton, I. Cooper, and R. W. Kelly, “Prostaglandin concentrations in the semen of fertile men,” Journal of Reproduction and Fertility, vol. 52, no. 1, pp. 147–150, 1978. View at Publisher · View at Google Scholar · View at Scopus
  81. E. H. Oliw, H. Sprecher, and M. Hamberg, “Isolation of two novel E prostaglandins in human seminal fluid,” The Journal of Biological Chemistry, vol. 261, no. 6, pp. 2675–2683, 1986. View at Google Scholar · View at Scopus
  82. H. J. Schuberth, U. Taylor, H. Zerbe, D. Waberski, R. Hunter, and D. Rath, “Immunological responses to semen in the female genital tract,” Theriogenology, vol. 70, no. 8, pp. 1174–1181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. K. J. Sales, A. A. Katz, B. Howard, R. P. Soeters, R. P. Millar, and H. N. Jabbour, “Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin E receptors, and angiogenic factors by cyclooxygenase-1,” Cancer Research, vol. 62, no. 2, pp. 424–432, 2002. View at Google Scholar · View at Scopus
  84. K. J. Sales, A. A. Katz, M. Davis et al., “Cyclooxygenase-2 expression and prostaglandin E2 synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 5, pp. 2243–2249, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. D. W. Fitzgerald, K. Bezak, O. Ocheretina et al., “The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels,” Cancer Prevention Research, vol. 5, no. 1, pp. 34–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. N. Dumais, “Emerging roles of prostaglandins in HIV-1 transcription,” in HIV and AIDS—Updates on Biology, Immunology, Epidemiology and Treatment Strategies, D. N. Dumais, Ed., pp. 346–370, InTech, Rijeka, Croatia, 2011. View at Google Scholar
  87. N. Yamamoto, S. Harada, and H. Nakashima, “Substances affecting the infection and replication of human immunodeficiency virus (HIV),” AIDS Research, vol. 2, supplement 1, pp. S183–S189, 1986. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Joseph, I. A. Zalenskaya, L. C. Sawyer, N. Chandra, and G. F. Doncel, “Seminal plasma induces prostaglandin-endoperoxide synthase (PTGS) 2 expression in immortalized human vaginal cells: involvement of semen prostaglandin E2 in PTGS2 upregulation,” Biology of Reproduction, vol. 88, no. 1, article 13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. A. O. Adefuye, K. J. Sales, and A. A. Katz, “Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway,” Journal of Molecular Signaling, vol. 9, article 8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. K. J. Sales, A. Adefuye, L. Nicholson, and A. A. Katz, “CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma,” Molecular Human Reproduction, vol. 20, no. 11, Article ID gau063, pp. 1144–1157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. D. Waberski, R. Claassen, T. Hahn et al., “LH profile and advancement of ovulation after transcervical infusion of seminal plasma at different stages of oestrus in gilts,” Journal of Reproduction and Fertility, vol. 109, no. 1, pp. 29–34, 1997. View at Publisher · View at Google Scholar · View at Scopus
  92. G. P. Adams, M. H. Ratto, W. Huanca, and J. Singh, “Ovulation-inducing factor in the seminal plasma of alpacas and llamas,” Biology of Reproduction, vol. 73, no. 3, pp. 452–457, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Brannstrom, N. Bonello, L. J. Wang, and R. J. Norman, “Effects of tumour necrosis factor α (TNFα) on ovulation in the rat ovary,” Reproduction, Fertility and Development, vol. 7, no. 1, pp. 67–73, 1995. View at Publisher · View at Google Scholar · View at Scopus
  94. I. Guleria and M. H. Sayegh, “Maternal acceptance of the fetus: true human tolerance,” The Journal of Immunology, vol. 178, no. 6, pp. 3345–3351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. V. R. Aluvihare, M. Kallikourdis, and A. G. Betz, “Regulatory T cells mediate maternal tolerance to the fetus,” Nature Immunology, vol. 5, no. 3, pp. 266–271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Beissert, A. Schwarz, and T. Schwarz, “Regulatory T cells,” Journal of Investigative Dermatology, vol. 126, no. 1, pp. 15–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. F. Baratelli, Y. Lin, L. Zhu et al., “Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells,” Journal of Immunology, vol. 175, no. 3, pp. 1483–1490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. W. Chen, W. Jin, N. Hardegen et al., “Conversion of peripheral CD4+CD25 naive T Cells to CD4+CD25+ regulatory T Cells by TGF-β induction of transcription factor Foxp3,” Journal of Experimental Medicine, vol. 198, no. 12, pp. 1875–1886, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. J. Kavanagh, A. J. Kelly, and J. Thomas, “Sexual intercourse for cervical ripening and induction of labour,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD003093, 2001. View at Google Scholar · View at Scopus
  100. J. W. Sublett and J. A. Bernstein, “Seminal plasma hypersensitivity reactions: an updated review,” Mount Sinai Journal of Medicine, vol. 78, no. 5, pp. 803–809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. D. Ghosh and J. A. Bernstein, “Systemic and localized seminal plasma hypersensitivity patients exhibit divergent immunologic characteristics,” Journal of Allergy and Clinical Immunology, vol. 134, no. 4, pp. 969–972, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Weidinger, J. Ring, and F. M. Köhn, “IgE-mediated allergy against human seminal plasma,” Chemical Immunology and Allergy, vol. 88, pp. 128–138, 2005. View at Google Scholar · View at Scopus
  103. S. J. Bashir and H. I. Maibach, “Contact urticaria syndrome,” Irritant Dermatitis, pp. 63–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. S. A. Robertson, “Seminal plasma and male factor signalling in the female reproductive tract,” Cell and Tissue Research, vol. 322, no. 1, pp. 43–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. H. N. Jabbour and K. J. Sales, “Prostaglandin receptor signalling and function in human endometrial pathology,” Trends in Endocrinology and Metabolism, vol. 15, no. 8, pp. 398–404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. K. J. Sales, S. C. Boddy, and H. N. Jabbour, “F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells,” Oncogene, vol. 27, no. 17, pp. 2466–2477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. P. G. Ney, “The intravaginal absorption of male generated hormones and their possible effect on female behaviour,” Medical Hypotheses, vol. 20, no. 2, pp. 221–231, 1986. View at Publisher · View at Google Scholar · View at Scopus
  108. K. J. Sales, A. A. Katz, R. P. Millar, and H. N. Jabbour, “Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells,” Molecular Human Reproduction, vol. 8, no. 12, pp. 1065–1070, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Muller, K. J. Sales, A. A. Katz, and H. N. Jabbour, “Seminal plasma promotes the expression of tumorigenic and angiogenic genes in cervical adenocarcinoma cells via the E-series prostanoid 4 receptor,” Endocrinology, vol. 147, no. 7, pp. 3356–3365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. J. R. Sutherland, K. J. Sales, H. N. Jabbour, and A. A. Katz, “Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo,” PLoS ONE, vol. 7, no. 3, Article ID e33848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. D. Wang and R. N. Dubois, “Eicosanoids and cancer,” Nature Reviews Cancer, vol. 10, no. 3, pp. 181–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. D. Hwang, D. Scollard, J. Byrne, and E. Levine, “Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer,” Journal of the National Cancer Institute, vol. 90, no. 6, pp. 455–460, 1998. View at Publisher · View at Google Scholar · View at Scopus
  113. K. J. Sales, J. R. Sutherland, H. N. Jabbour, and A. A. Katz, “Seminal plasma induces angiogenic chemokine expression in cervical cancer cells and regulates vascular function,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1823, no. 10, pp. 1789–1795, 2012. View at Publisher · View at Google Scholar · View at Scopus
  114. S. P. Herbert, A. F. Odell, S. Ponnambalam, and J. H. Walker, “The confluence-dependent interaction of cytosolic phospholipase A 2-α with annexin A1 regulates endothelial cell prostaglandin E2 generation,” Journal of Biological Chemistry, vol. 282, no. 47, pp. 34469–34478, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Murakami, H. Naraba, T. Tanioka et al., “Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2,” The Journal of Biological Chemistry, vol. 275, no. 42, pp. 32783–32792, 2000. View at Publisher · View at Google Scholar · View at Scopus
  116. L. Forsberg, L. Leeb, S. Thorén, R. Morgenstern, and P.-J. Jakobsson, “Human glutathione dependent prostaglandin E synthase: gene structure and regulation,” FEBS Letters, vol. 471, no. 1, pp. 78–82, 2000. View at Publisher · View at Google Scholar · View at Scopus
  117. R. Jones, L.-A. Adel-Alvarez, O. R. Alvarez, R. Broaddus, and S. Das, “Arachidonic acid and colorectal carcinogenesis,” Molecular and Cellular Biochemistry, vol. 253, no. 1-2, pp. 141–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  118. J. R. Mann, M. G. Backlund, F. G. Buchanan et al., “Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression,” Cancer Research, vol. 66, no. 13, pp. 6649–6656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. D. Wang and R. N. DuBois, “Pro-inflammatory prostaglandins and progression of colorectal cancer,” Cancer Letters, vol. 267, no. 2, pp. 197–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. C. M. Ensor and H.-H. Tai, “15-Hydroxyprostaglandin dehydrogenase,” Journal of Lipid Mediators and Cell Signalling, vol. 12, no. 2-3, pp. 313–319, 1995. View at Publisher · View at Google Scholar · View at Scopus
  121. S. Tseng-Rogenski, J. Gee, K. W. Ignatoski et al., “Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression,” American Journal of Pathology, vol. 176, no. 3, pp. 1462–1468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. Z. Liu, X. Wang, Y. Lu et al., “Expression of 15-PGDH is downregulated by COX-2 in gastric cancer,” Carcinogenesis, vol. 29, no. 6, pp. 1219–1227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. I. Wolf, J. O'Kelly, T. Rubinek et al., “15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer,” Cancer Research, vol. 66, no. 15, pp. 7818–7823, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. S.-J. Myung, R. M. Rerko, M. Yan et al., “15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 32, pp. 12098–12102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. B. Frank, B. Hoeft, M. Hoffmeister et al., “Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk,” Carcinogenesis, vol. 32, no. 2, pp. 190–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Yan, S.-J. Myung, S. P. Fink et al., “15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 23, pp. 9409–9413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. Y. I. Cha and R. N. DuBois, “NSAIDs and cancer prevention: targets downstream of COX-2,” Annual Review of Medicine, vol. 58, pp. 239–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. W. R. Henderson Jr., “The role of leukotrienes in inflammation,” Annals of Internal Medicine, vol. 121, no. 9, pp. 684–697, 1994. View at Publisher · View at Google Scholar · View at Scopus
  129. H. Hasturk, A. Kantarci, E. Goguet-Surmenian et al., “Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo,” Journal of Immunology, vol. 179, no. 10, pp. 7021–7029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. B. K. Lam, “Leukotriene C4 synthase,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 69, no. 2-3, pp. 111–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  131. C. Brink, S.-E. Dahlen, J. Drazen et al., “International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors,” Pharmacological Reviews, vol. 55, no. 1, pp. 195–227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. V. Capra, “Molecular and functional aspects of human cysteinyl leukotriene receptors,” Pharmacological Research, vol. 50, no. 1, pp. 1–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  133. J. F. Öhd, C. K. Nielsen, J. Campbell, G. Landberg, H. Löfberg, and A. Sjölander, “Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas,” Gastroenterology, vol. 124, no. 1, pp. 57–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  134. M. Matsuyama, T. Hayama, K. Funao et al., “Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis,” Oncology Reports, vol. 18, no. 1, pp. 99–104, 2007. View at Google Scholar · View at Scopus
  135. C. A. Borgoño and E. P. Diamandis, “The emerging roles of human tissue kallikreins in cancer,” Nature Reviews Cancer, vol. 4, no. 11, pp. 876–890, 2004. View at Publisher · View at Google Scholar · View at Scopus
  136. N. Emami and E. P. Diamandis, “New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family,” Molecular Oncology, vol. 1, no. 3, pp. 269–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. D. Proud and A. P. Kaplan, “Kinin formation: mechanisms and role in inflammatory disorders,” Annual Review of Immunology, vol. 6, pp. 49–83, 1988. View at Publisher · View at Google Scholar · View at Scopus
  138. D. Regoli and J. Barabé, “Pharmacology of bradykinin and related kinins,” Pharmacological Reviews, vol. 32, no. 1, pp. 1–46, 1980. View at Google Scholar · View at Scopus
  139. J. B. Calixto, R. Medeiros, E. S. Fernandes, J. Ferreira, D. A. Cabrini, and M. M. Campos, “Kinin B 1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes,” British Journal of Pharmacology, vol. 143, no. 7, pp. 803–818, 2004. View at Publisher · View at Google Scholar · View at Scopus
  140. X. Li, S. Jiang, and R. I. Tapping, “Toll-like receptor signaling in cell proliferation and survival,” Cytokine, vol. 49, no. 1, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  141. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Publisher · View at Google Scholar · View at Scopus
  142. W. Xie, Y. Wang, Y. Huang, H. Yang, J. Wang, and Z. Hu, “Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 379, no. 4, pp. 1027–1032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. C.-Y. Hsieh, S.-L. You, C.-L. Kao, and C.-J. Chen, “Reproductive and infectious risk factors for invasive cervical cancer in Taiwan,” Anticancer Research, vol. 19, no. 5, pp. 4495–4500, 1999. View at Google Scholar · View at Scopus
  144. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  145. F. Balkwill, K. A. Charles, and A. Mantovani, “Smoldering and polarized inflammation in the initiation and promotion of malignant disease,” Cancer Cell, vol. 7, no. 3, pp. 211–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  146. A. Mantovani, “Cancer: inflaming metastasis,” Nature, vol. 457, no. 7225, pp. 36–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  147. S. Ali and G. Lazennec, “Chemokines: novel targets for breast cancer metastasis,” Cancer and Metastasis Reviews, vol. 26, no. 3-4, pp. 401–420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. D. Vindrieux, P. Escobar, and G. Lazennec, “Emerging roles of chemokines in prostate cancer,” Endocrine-Related Cancer, vol. 16, no. 3, pp. 663–673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. A. Mantovani, P. Allavena, S. Sozzani, A. Vecchi, M. Locati, and A. Sica, “Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors,” Seminars in Cancer Biology, vol. 14, no. 3, pp. 155–160, 2004. View at Publisher · View at Google Scholar · View at Scopus
  150. J. C. Chen, B. A. Johnson, D. W. Erikson et al., “Seminal plasma induces global transcriptomic changes associated with cell migration, proliferation and viability in endometrial epithelial cells and stromal fibroblasts,” Human Reproduction, vol. 29, no. 6, pp. 1255–1270, 2014. View at Publisher · View at Google Scholar · View at Scopus
  151. J. E. Schjenken, D. J. Glynn, D. J. Sharkey, and S. A. Robertson, “TLR4 signaling is a major mediator of the female tract response to seminal fluid in mice,” Biology of Reproduction, vol. 93, article 68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  152. H. Wakabayashi, P. G. Cavanaugh, and G. L. Nicolson, “Purification and identification of mouse lung microvessel endothelial cell-derived chemoattractant for lung-metastasizing murine RAW117 large-cell lymphoma cells: identification as mouse monocyte chemotactic protein 1,” Cancer Research, vol. 55, no. 19, pp. 4458–4464, 1995. View at Google Scholar · View at Scopus
  153. D. Wang, H. Wang, J. Brown et al., “CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer,” Journal of Experimental Medicine, vol. 203, no. 4, pp. 941–951, 2006. View at Publisher · View at Google Scholar · View at Scopus
  154. G. Castrilli, D. Tatone, M. G. Diodoro, S. Rosini, M. Piantelli, and P. Musiani, “Interleukin 1α and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells,” British Journal of Cancer, vol. 75, no. 6, pp. 855–859, 1997. View at Publisher · View at Google Scholar · View at Scopus
  155. X. Chen, S. Han, S. Wang et al., “Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women,” Clinical Cancer Research, vol. 15, no. 1, pp. 400–405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. A. J. Puren, G. Fantuzzi, Y. Gu, M. S.-S. Su, and C. A. Dinarello, “Interleukin-18 (IFNγ-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells,” The Journal of Clinical Investigation, vol. 101, no. 3, pp. 711–721, 1998. View at Publisher · View at Google Scholar · View at Scopus
  157. G. Trinchieri, “Interleukin-12 and the regulation of innate resistance and adaptive immunity,” Nature Reviews Immunology, vol. 3, no. 2, pp. 133–146, 2003. View at Publisher · View at Google Scholar · View at Scopus
  158. T. D. de Gruijl, H. J. Bontkes, A. J. C. Van den Muysenberg et al., “Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix,” European Journal of Cancer, vol. 35, no. 3, pp. 490–497, 1999. View at Publisher · View at Google Scholar · View at Scopus
  159. K. A. Paschos, D. Canovas, and N. C. Bird, “The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis,” Cellular Signalling, vol. 21, no. 5, pp. 665–674, 2009. View at Publisher · View at Google Scholar · View at Scopus